Invitrogen Teams with Genisphere to Advance Epigenetic Research
CARLSBAD, Calif. & HATFIELD, Pa., Feb 27, 2008 (BUSINESS WIRE) -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will become the exclusive provider of fluorescent microRNA microarray labeling kits using Genisphere Inc.'s 3DNA(R: 59.28, -1.31, -2.16%) dendrimer signal amplification technology, based on the terms of a new license agreement. This technology, combined with Invitrogen's Alexa Fluor(R: 59.28, -1.31, -2.16%) fluorescent dyes, is now commercialized in the new NCode(TM: 110.98, -1.89, -1.67%) Rapid miRNA Labeling System, available from Invitrogen.
